Effect of Ultrasound Cavitation Versus Whole Body Vibration on Abdominal Fat in Obese Adolescent Females
Launched by CAIRO UNIVERSITY · Jul 26, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to compare two different treatments—ultrasound cavitation and whole-body vibration—to see which one is more effective at reducing abdominal fat in overweight teenage girls. The study will focus on girls aged 17 to 25 who have a higher amount of fat around their waist and meet specific health criteria.
To be eligible for this trial, participants must be female adolescents with a body mass index (BMI) between 30 and 35, a waist measurement greater than 88 cm, and a waist-to-hip ratio above 0.88. However, girls with certain health issues, such as thyroid problems, diabetes, or recent surgeries involving the abdomen, will not be included. If you or someone you know fits these criteria and is interested, this study could offer an opportunity to learn about effective ways to manage abdominal obesity. Participants can expect to undergo one of the two treatments and contribute to important research that could help others in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adolescent females suffer from abdominal obesity.
- • Their ages will be ranged from 17 to 25 years old.
- • Their body mass index (BMI) will be ranged from 30 to 35 kg/m2.
- • Their waist circumference will be \> 88 cm.
- • Their WHR will be more than 0.88.
- Exclusion Criteria:
- Females will be excluded from the study if they have:
- • Thyroid, hepatic and kidney disorders.
- • Diabetes mellitus, coronary artery diseases, hypertension and congestive heart failure.
- • Recent abdominal surgical scar or umbilical hernia.
- • History of orthopedic implants insertion or cardiac pacemaker implantation.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Azza Kassab
Study Chair
Cairo University
Manal El-Shafei
Study Director
Cairo University
Mohamed AboEleinen
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported